Total Payments
$66,030
2024 Payments
$35,144
Companies
15
Transactions
187
Medicare Patients
201
Medicare Billing
$26,462
Payment Breakdown by Category
Other$49,522 (75.0%)
Consulting$8,376 (12.7%)
Travel$4,206 (6.4%)
Food & Beverage$3,827 (5.8%)
Education$99.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,522 | 17 | 75.0% |
| Consulting Fee | $8,376 | 1 | 12.7% |
| Travel and Lodging | $4,206 | 8 | 6.4% |
| Food and Beverage | $3,827 | 160 | 5.8% |
| Education | $99.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $48,017 | 41 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $15,627 | 19 | $0 (2024) |
| ABBVIE INC. | $852.14 | 53 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $487.04 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $343.55 | 21 | $0 (2023) |
| QOL Medical, LLC | $271.51 | 11 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $140.73 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $70.90 | 3 | $0 (2023) |
| Lilly USA, LLC | $70.18 | 3 | $0 (2024) |
| UCB, Inc. | $34.33 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,144 | 55 | GENZYME CORPORATION ($27,753) |
| 2023 | $17,194 | 44 | GENZYME CORPORATION ($12,690) |
| 2022 | $12,735 | 27 | GENZYME CORPORATION ($7,575) |
| 2021 | $231.24 | 22 | AbbVie Inc. ($142.76) |
| 2020 | $48.56 | 3 | Janssen Biotech, Inc. ($28.99) |
| 2019 | $236.30 | 12 | Janssen Biotech, Inc. ($181.00) |
| 2018 | $275.76 | 18 | AbbVie, Inc. ($187.31) |
| 2017 | $164.83 | 6 | AbbVie, Inc. ($140.57) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,839.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $602.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: INFLIXIMAB | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: Immunology | ||||||
| 11/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: GI | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,443.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: INFLIXIMAB | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $49.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $87.82 | General |
| Category: GI | ||||||
| 09/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.30 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 08/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.31 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 06/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $126.57 | General |
| Category: Immunology | ||||||
| 06/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 38 | $11,799 | $3,176 |
| 2022 | 5 | 60 | 91 | $34,900 | $8,812 |
| 2021 | 2 | 29 | 51 | $11,827 | $4,222 |
| 2020 | 6 | 79 | 94 | $49,729 | $10,252 |
Total Patients
201
Total Services
274
Medicare Billing
$26,462
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 23 | $6,969 | $1,654 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,830 | $1,522 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 36 | $9,005 | $2,890 | 32.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 11 | 11 | $14,129 | $2,201 | 15.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $5,722 | $1,698 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 20 | $4,400 | $1,444 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,644 | $579.71 | 35.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 31 | $7,967 | $2,633 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 20 | $3,860 | $1,588 | 41.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 13 | 13 | $14,183 | $2,471 | 17.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 11 | 11 | $16,098 | $2,305 | 14.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $7,515 | $2,278 | 30.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 23 | $5,911 | $1,805 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 21 | $4,053 | $814.31 | 20.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 11 | 11 | $1,969 | $578.96 | 29.4% |
About Dr. Vidhya Kunnathur, M.D
Dr. Vidhya Kunnathur, M.D is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477715647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vidhya Kunnathur, M.D has received a total of $66,030 in payments from pharmaceutical and medical device companies, with $35,144 received in 2024. These payments were reported across 187 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,522).
As a Medicare-enrolled provider, Kunnathur has provided services to 201 Medicare beneficiaries, totaling 274 services with total Medicare billing of $26,462. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Cincinnati, OH
- Active Since 06/30/2008
- Last Updated 07/10/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477715647
Products in Payments
- DUPIXENT (Biological) $50,582
- Humira (Biological) $276.06
- ENTYVIO (Biological) $252.79
- STELARA (Biological) $233.64
- RINVOQ (Biological) $168.83
- HUMIRA (Biological) $162.33
- Linzess (Drug) $140.73
- SUCRAID (Drug) $137.15
- Sucraid (Drug) $134.36
- EOHILIA (Drug) $128.81
- GATTEX (Drug) $111.73
- REMICADE (Biological) $109.91
- SKYRIZI (Biological) $83.13
- VIBERZI (Drug) $74.57
- OMVOH (Drug) $70.18
- Creon (Drug) $51.82
- XIFAXAN (Drug) $46.19
- Cimzia (Drug) $34.33
- RENFLEXIS (Drug) $32.42
- XELJANZ (Drug) $28.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cincinnati
Jonathan Bernstein, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Nelson Watts, M.d, M.D
Internal Medicine — Payments: $788,194
Internal Medicine $788,194
Robert Baughman, M.d, M.D
Internal Medicine — Payments: $766,919
Internal Medicine $766,919
Mark Andolina, Md, MD
Internal Medicine — Payments: $469,821
Internal Medicine $469,821
Amit Govil, M.d, M.D
Internal Medicine — Payments: $410,360
Internal Medicine $410,360
Vincent Martin, Md, MD
Internal Medicine — Payments: $332,673
Internal Medicine $332,673